Literature DB >> 25249805

Reducing peritoneal dialysis-related peritonitis rate.

Anupkumar Shetty1.   

Abstract

BACKGROUND: Peritoneal dialysis-related peritonitis is an important negative risk of peritoneal dialysis. Peritonitis results when organisms enter the normally sterile peritoneal space, and the peritoneal immune system is unable to prevent the proliferation of the organisms.
METHODS: The process of reducing the rate of peritonitis includes identification of the need for reducing peritonitis, identification of the cause of the high peritonitis rate through root cause analysis, and intervention.
RESULTS: Interventions vary depending upon the type of organism causing peritonitis. Nonenterococcal gram-positive peritonitis and Pseudomonas peritonitis are related to contamination and are potentially preventable; enteric peritonitis is difficult to prevent.
CONCLUSION: The rate of peritonitis can be reduced through a strong continuous quality improvement team because the majority of peritonitis episodes can be prevented.

Entities:  

Keywords:  Peritoneal dialysis; peritoneal dialysis–continuous ambulatory; peritonitis

Year:  2014        PMID: 25249805      PMCID: PMC4171797     

Source DB:  PubMed          Journal:  Ochsner J        ISSN: 1524-5012


  10 in total

Review 1.  ISPD position statement on reducing the risks of peritoneal dialysis-related infections.

Authors:  Beth Piraino; Judith Bernardini; Edwina Brown; Ana Figueiredo; David W Johnson; Wai-Choong Lye; Valerie Price; Santhanam Ramalakshmi; Cheuk-Chun Szeto
Journal:  Perit Dial Int       Date:  2011-08-31       Impact factor: 1.756

2.  A randomized trial of Staphylococcus aureus prophylaxis in peritoneal dialysis patients: mupirocin calcium ointment 2% applied to the exit site versus cyclic oral rifampin.

Authors:  J Bernardini; B Piraino; J Holley; J R Johnston; R Lutes
Journal:  Am J Kidney Dis       Date:  1996-05       Impact factor: 8.860

3.  A randomized controlled trial comparing mupirocin and polysporin triple ointments in peritoneal dialysis patients: the MP3 Study.

Authors:  Rory F McQuillan; Ernest Chiu; Sharon Nessim; Charmaine E Lok; Janet M Roscoe; Paul Tam; Sarbjit Vanita Jassal
Journal:  Clin J Am Soc Nephrol       Date:  2011-12-01       Impact factor: 8.237

4.  Randomized, double-blind trial of antibiotic exit site cream for prevention of exit site infection in peritoneal dialysis patients.

Authors:  Judith Bernardini; Filitsa Bender; Tracey Florio; James Sloand; Linda Palmmontalbano; Linda Fried; Beth Piraino
Journal:  J Am Soc Nephrol       Date:  2004-12-29       Impact factor: 10.121

5.  Nasal mupirocin prevents Staphylococcus aureus exit-site infection during peritoneal dialysis. Mupirocin Study Group.

Authors: 
Journal:  J Am Soc Nephrol       Date:  1996-11       Impact factor: 10.121

Review 6.  Pets-related peritonitis in peritoneal dialysis: companion animals or trojan horses?

Authors:  Ashley Broughton; Christian Verger; Eric Goffin
Journal:  Semin Dial       Date:  2010 May-Jun       Impact factor: 3.455

7.  Fivefold reduction in peritonitis using a multifaceted continuous quality initiative program.

Authors:  Diane Borg; Anupkumar Shetty; Deborah Williams; Mark D Faber
Journal:  Adv Perit Dial       Date:  2003

8.  Hypokalaemia: an independent risk factor of Enterobacteriaceae peritonitis in CAPD patients.

Authors:  Ya-Wen Chuang; Kuo-Hsiung Shu; Tung-Min Yu; Chi-Hung Cheng; Cheng-Hsu Chen
Journal:  Nephrol Dial Transplant       Date:  2008-12-22       Impact factor: 5.992

9.  Touch contamination of connection devices in peritoneal dialysis--a quantitative microbiologic analysis.

Authors:  T E Miller; G Findon
Journal:  Perit Dial Int       Date:  1997 Nov-Dec       Impact factor: 1.756

10.  Decrease in Staphylococcus aureus exit-site infections and peritonitis in CAPD patients by local application of mupirocin ointment at the catheter exit site.

Authors:  E Thodis; S Bhaskaran; P Pasadakis; J M Bargman; S I Vas; D G Oreopoulos
Journal:  Perit Dial Int       Date:  1998 May-Jun       Impact factor: 1.756

  10 in total
  2 in total

1.  Benefit of an operating vehicle preventing peritonitis in peritoneal dialysis patients: a retrospective, case-controlled study.

Authors:  Pan Fang; Jia Lu; Ying-Hong Liu; Hong-Mei Deng; Lei Zhang; Hong-Qing Zhang
Journal:  Int Urol Nephrol       Date:  2018-03-05       Impact factor: 2.370

2.  Fungal peritonitis in peritoneal dialysis: a 34-year single centre evaluation.

Authors:  Sara Auricchio; Maria Enrica Giovenzana; Marco Pozzi; Andrea Galassi; Gennaro Santorelli; Beatrice Dozio; Renzo Scanziani
Journal:  Clin Kidney J       Date:  2018-07-18
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.